在多发性髓瘤中,BCL7A的丧失允许IRF4转录活动和细胞生长
Chandraditya Chakraborty1, Srikanth Talluri2, Moritz Binder3
1Dana Farber Cancer Institute, Boston, Massachusetts, United States.
Blood
|March 16, 2025
概括
失去BCL7A基因是多发性骨髓瘤 (MM),一种血液癌症的频繁事件. 这种损失通过影响IRF4蛋白质促进癌细胞生长,表明BCL7A作为瘤抑制剂.
科学领域:
- 血液学 血液学 血液学
- 癌症基因组学 癌症基因组学
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有复杂的遗传和转录基因变异的血液性恶性瘤.
- 以前的外基因组测序未能在MM中发现一致的突变.
- 全基因组测序 (WGS) 对于发现非编码突变至关重要.
研究的目的:
- 在多发性骨髓瘤中识别频繁突变的基因组区域.
- 调查BCL7A基因在MM病变发生过程中的功能性作用.
- 阐明BCL7A损失导致MM进展的分子机制.
主要方法:
- 在MM患者样本中进行全基因组测序 (WGS).
- RNA测序 (RNA-seq) 用于评估基因表达.
- 使用MM细胞系 (体外和体内) 的功能研究.
- 分析蛋白质与蛋白质相互作用和细胞代谢.
主要成果:
- 在MM患者中,BCL7A的5' UTR和/或内突1经常发生突变 (62%).
- 与正常血细胞相比,大多数MM患者的BCL7A表达显著降低.
- BCL7A损失促进了MM细胞的增殖和存活,这表明瘤抑制作用.
- BCL7A与IRF4相互作用,抑制其DNA结合并调节下游基因表达,新陈代谢和ROS水平.
结论:
- 在多发性骨髓瘤的发展中,BCL7A损失是关键的分子事件.
- BCL7A通过调节IRF4活动,起到瘤抑制作用.
- 了解BCL7A的作用为MM提供了潜在的治疗点.
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
01:31The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K